EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor

Yan Wang, Zeng Ye, Xin Lou, Junfeng Xu, Desheng Jing, Chenjie Zhou, Yi Qin, Jie Chen, Xiaowu Xu, Xianjun Yu, Shunrong Ji

Human Cell · 2024

DOI: 10.1007/s13577-024-01107-5 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Human Cell, 2024. Verfasst von Yan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic neuroendocrine tumors are the second most common tumors of the pancreas, and approximately half of patients are diagnosed with liver metastases. Currently, the improvement in the efficacy of relevant treatment methods is still limited. Therefore, there is an urgent need for in-depth research on the molecular biological mechanism of pancreatic neuroendocrine tumors. However, due to their relatively inert biology, preclinical models are extremely scarce. Here, the patient-derived organoid, and patient-derived xenograft were successfully constructed. These two models and the previously constructed cell line named SPNE1 all derived from the same patient with a grade 3 non-functional pancreatic neuroendocrine tumor, providing new tumor modeling platforms, and characterized using immunohistochemistry, whole-exome sequencing, and single-cell transcriptome sequencing. Combined with a tumor formation experiment in immunodeficient mice, we selected the model that most closely recapitulated the parental tumor. Overall, the patient-derived xenograft model most closely resembled human tumor tissue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeuroendocrine TumorsHumansAnimalsDisease Models, AnimalMiceHeterograftsCell Line, TumorOrganoidsExome Sequencing

Stichwörter der Autor:innen

Cell linePancreatic neuroendocrine tumorPatient-derived organoidPatient-derived xenograftPreclinical model

Autor:innen und Institutionen

  • Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Center for Neuroendocrine Tumors, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China.
  • Pancreatic Cancer Institute, Fudan University, Shanghai, 200032, China.
  • Department of Head and Neck and Neuroendocrine Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Ye, Z., Lou, X., Xu, J., Jing, D., Zhou, C., Qin, Y., Chen, J., Xu, X., Yu, X., & Ji, S. (2024). Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor. Human Cell. https://doi.org/10.1007/s13577-024-01107-5

Vancouver

Wang Y, Ye Z, Lou X, Xu J, Jing D, Zhou C, et al. Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor. Human Cell. 2024. doi:10.1007/s13577-024-01107-5

BibTeX
@article{Wang2024,
  author = {Wang, Yan and Ye, Zeng and Lou, Xin and Xu, Junfeng and Jing, Desheng and Zhou, Chenjie and Qin, Yi and Chen, Jie and Xu, Xiaowu and Yu, Xianjun and Ji, Shunrong},
  title = {Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor},
  journal = {Human Cell},
  year = {2024},
  doi = {10.1007/s13577-024-01107-5}
}
Kostenlos starten →